Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network

Yuda Turana; Jeslyn Tengkawan; Yook C. Chia; Jinho Shin; Chen Huan Chen; Sungha Park; Kelvin Tsoi; Peera Buranakitjaroen; Arieska A. Soenarta; Saulat Siddique; Hao Min Cheng; Jam C. Tay; Boon W. Teo; Tzung Dau Wang; Kazuomi Kario

doi:10.1111/jch.14121

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network

Yuda Turana, Jeslyn Tengkawan, Yook C. Chia, Jinho Shin, Chen Huan Chen, Sungha Park, Kelvin Tsoi, Peera Buranakitjaroen, Arieska A. Soenarta, Saulat Siddique, Hao Min Cheng, Jam C. Tay, Boon W. Teo, Tzung Dau Wang, Kazuomi Kario

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

Abstract

The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems.

Original language	English
Pages (from-to)	504-512
Number of pages	9
Journal	Journal of Clinical Hypertension
Volume	23
Issue number	3
DOIs	https://doi.org/10.1111/jch.14121
Publication status	Published - 2021 Mar

Bibliographical note

Funding Information:
YC Chia has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Abbott, Bayer, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Omron, Pfizer, and Sanofi and Xepa‐Soul Pattinson, and a research grant from Pfizer Inc J Shin has received lecture honoraria from Pfizer Inc, Hanmi Pharm. Co. Ltd., Yuhan Co. Ltd., Boryung Pharmaceutical Co. Ltd., consulting fees from Hanmi Pharm. Co. Ltd., and research grants from Sanofi Pharm. and Hanmi Pharm. Co. Ltd. CH Chen reports personal fees from Novartis, Sanofi, Daiichi Sankyo, Servier, and Boehringer Ingelheim Pharmaceuticals Inc S Park has received honoraria from Pfizer Inc, Daiichi Sankyo, Takeda Pharmaceuticals International, Daewon Pharmaceutical Company, Boryung Pharmaceutical Company, and Servier. S Park has also received a research grant from Daiichi Sankyo. S Siddique has received honoraria from Bayer, Novartis, Pfizer Inc, ICI, and Servier, and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. HM Cheng has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Eli Lilly and AstraZeneca; Pfizer Inc, Bayer AG, Boehringer Ingelheim Pharmaceuticals Inc, Daiichi Sankyo, Novartis Pharmaceuticals Inc Servier, Sanofi, and Takeda Pharmaceuticals International, and has served as an advisor or consultant for ApoDx Technology Inc K Kario received a research grant from MSD K.K, Astellas Pharma Inc, Eisai Co., Otsuka Pharmaceutical Co., Sanwa Kagaku Kenkyusho Co., Daiichi Sankyo Co., Taisho Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Co., Teijin Pharma, Boehringer Ingelheim Japan Inc, Bristol‐Myers Squibb K.K, and Mochida Pharmaceutical Co. Ltd., and honoraria from Daiichi Sankyo Co. Ltd. and Mylan EPD. All other authors report no potential conflicts of interest in relation to this article.

Publisher Copyright:
© 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jch.14121

Cite this

Turana, Y., Tengkawan, J., Chia, Y. C., Shin, J., Chen, C. H., Park, S., Tsoi, K., Buranakitjaroen, P., Soenarta, A. A., Siddique, S., Cheng, H. M., Tay, J. C., Teo, B. W., Wang, T. D., & Kario, K. (2021). Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network. Journal of Clinical Hypertension, 23(3), 504-512. https://doi.org/10.1111/jch.14121

@article{4286b6e063ea4b338293ced336c6cb87,

title = "Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network",

abstract = "The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems.",

author = "Yuda Turana and Jeslyn Tengkawan and Chia, {Yook C.} and Jinho Shin and Chen, {Chen Huan} and Sungha Park and Kelvin Tsoi and Peera Buranakitjaroen and Soenarta, {Arieska A.} and Saulat Siddique and Cheng, {Hao Min} and Tay, {Jam C.} and Teo, {Boon W.} and Wang, {Tzung Dau} and Kazuomi Kario",

note = "Funding Information: YC Chia has received speakers{\textquoteright} honorarium and sponsorship to attend conferences and CME seminars from Abbott, Bayer, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Omron, Pfizer, and Sanofi and Xepa‐Soul Pattinson, and a research grant from Pfizer Inc J Shin has received lecture honoraria from Pfizer Inc, Hanmi Pharm. Co. Ltd., Yuhan Co. Ltd., Boryung Pharmaceutical Co. Ltd., consulting fees from Hanmi Pharm. Co. Ltd., and research grants from Sanofi Pharm. and Hanmi Pharm. Co. Ltd. CH Chen reports personal fees from Novartis, Sanofi, Daiichi Sankyo, Servier, and Boehringer Ingelheim Pharmaceuticals Inc S Park has received honoraria from Pfizer Inc, Daiichi Sankyo, Takeda Pharmaceuticals International, Daewon Pharmaceutical Company, Boryung Pharmaceutical Company, and Servier. S Park has also received a research grant from Daiichi Sankyo. S Siddique has received honoraria from Bayer, Novartis, Pfizer Inc, ICI, and Servier, and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. HM Cheng has received speakers{\textquoteright} honorarium and sponsorship to attend conferences and CME seminars from Eli Lilly and AstraZeneca; Pfizer Inc, Bayer AG, Boehringer Ingelheim Pharmaceuticals Inc, Daiichi Sankyo, Novartis Pharmaceuticals Inc Servier, Sanofi, and Takeda Pharmaceuticals International, and has served as an advisor or consultant for ApoDx Technology Inc K Kario received a research grant from MSD K.K, Astellas Pharma Inc, Eisai Co., Otsuka Pharmaceutical Co., Sanwa Kagaku Kenkyusho Co., Daiichi Sankyo Co., Taisho Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Co., Teijin Pharma, Boehringer Ingelheim Japan Inc, Bristol‐Myers Squibb K.K, and Mochida Pharmaceutical Co. Ltd., and honoraria from Daiichi Sankyo Co. Ltd. and Mylan EPD. All other authors report no potential conflicts of interest in relation to this article. Publisher Copyright: {\textcopyright} 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC",

year = "2021",

month = mar,

doi = "10.1111/jch.14121",

language = "English",

volume = "23",

pages = "504--512",

journal = "Journal of Clinical Hypertension",

issn = "1524-6175",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Mental health problems and hypertension in the elderly

T2 - Review from the HOPE Asia Network

AU - Turana, Yuda

AU - Tengkawan, Jeslyn

AU - Chia, Yook C.

AU - Shin, Jinho

AU - Chen, Chen Huan

AU - Park, Sungha

AU - Tsoi, Kelvin

AU - Buranakitjaroen, Peera

AU - Soenarta, Arieska A.

AU - Siddique, Saulat

AU - Cheng, Hao Min

AU - Tay, Jam C.

AU - Teo, Boon W.

AU - Wang, Tzung Dau

AU - Kario, Kazuomi

N1 - Funding Information: YC Chia has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Abbott, Bayer, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Omron, Pfizer, and Sanofi and Xepa‐Soul Pattinson, and a research grant from Pfizer Inc J Shin has received lecture honoraria from Pfizer Inc, Hanmi Pharm. Co. Ltd., Yuhan Co. Ltd., Boryung Pharmaceutical Co. Ltd., consulting fees from Hanmi Pharm. Co. Ltd., and research grants from Sanofi Pharm. and Hanmi Pharm. Co. Ltd. CH Chen reports personal fees from Novartis, Sanofi, Daiichi Sankyo, Servier, and Boehringer Ingelheim Pharmaceuticals Inc S Park has received honoraria from Pfizer Inc, Daiichi Sankyo, Takeda Pharmaceuticals International, Daewon Pharmaceutical Company, Boryung Pharmaceutical Company, and Servier. S Park has also received a research grant from Daiichi Sankyo. S Siddique has received honoraria from Bayer, Novartis, Pfizer Inc, ICI, and Servier, and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. HM Cheng has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Eli Lilly and AstraZeneca; Pfizer Inc, Bayer AG, Boehringer Ingelheim Pharmaceuticals Inc, Daiichi Sankyo, Novartis Pharmaceuticals Inc Servier, Sanofi, and Takeda Pharmaceuticals International, and has served as an advisor or consultant for ApoDx Technology Inc K Kario received a research grant from MSD K.K, Astellas Pharma Inc, Eisai Co., Otsuka Pharmaceutical Co., Sanwa Kagaku Kenkyusho Co., Daiichi Sankyo Co., Taisho Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Co., Teijin Pharma, Boehringer Ingelheim Japan Inc, Bristol‐Myers Squibb K.K, and Mochida Pharmaceutical Co. Ltd., and honoraria from Daiichi Sankyo Co. Ltd. and Mylan EPD. All other authors report no potential conflicts of interest in relation to this article. Publisher Copyright: © 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC

PY - 2021/3

Y1 - 2021/3

N2 - The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems.

AB - The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems.

UR - http://www.scopus.com/inward/record.url?scp=85097219445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097219445&partnerID=8YFLogxK

U2 - 10.1111/jch.14121

DO - 10.1111/jch.14121

M3 - Review article

C2 - 33283971

AN - SCOPUS:85097219445

SN - 1524-6175

VL - 23

SP - 504

EP - 512

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

IS - 3

ER -

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this